Tsvetelina Pencheva Hoang
Chief Tech/Sci/R&D Officer presso MARKER THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Tsvetelina Pencheva Hoang is currently the Vice President-Research & Development at Marker Therapeutics, Inc. She previously worked as the Director-Translational Research at Bellicum Pharmaceuticals, Inc. from 2015 to 2018.
Before that, she was a Member at Memorial Sloan Kettering Cancer Center.
From 2013 to 2015, she worked as a Member at The University of Texas M.D.
Anderson Cancer Center.
She also held a position as a Member at The Phi Beta Kappa Society.
Dr. Hoang holds a doctorate degree from The Johns Hopkins University and undergraduate and graduate degrees from Yale University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 27/02/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Tsvetelina Pencheva Hoang
| Società | Posizione | Inizio |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 23/10/2018 |
Precedenti posizioni note di Tsvetelina Pencheva Hoang
| Società | Posizione | Fine |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2018 |
The Phi Beta Kappa Society
 The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Corporate Officer/Principal | - |
Formazione di Tsvetelina Pencheva Hoang
| The Johns Hopkins University | Doctorate Degree |
| Yale University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Commercial Services |
- Borsa valori
- Insiders
- Tsvetelina Pencheva Hoang
